• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Pyrrolobenzodiazepine

From across the pond, 2017’s brightest European biotech stars; perhaps under US’s radar, but still ready to soar?

Steve Walker    December 14, 2017 December 14, 2017    No Comments on From across the pond, 2017’s brightest European biotech stars; perhaps under US’s radar, but still ready to soar?

Many said good riddance to 2016 for biotech and pharma; things could only get better this year–and the European industry didn’t disappoint, says Labiotech.eu, the quintessential industry observer and news… Read more »

Corporate, Investment, Pharmaceuticals    Ablynx NV, Actelion Pharmaceuticals Ltd., ADC Therapeutics Sarl, Alnylam Pharmaceuticals Inc., Arzerra, Bicycle Therapeutics Ltd., Bioverativ Inc., Caplacizumab, CAR-T Therapies, Darzalex, Edwin Moses, ERYtech Pharma SA, Exscientia Ltd., Genmab A/S, Jan van de Winkel, Janssen Biotech Inc., Johnson & Johnson, Labiotech.eu, Novartis AG, Pierre-Olivier Goineau, Pyrrolobenzodiazepine, Rigontec GmbH, Sanofi SA, Yann Godfrin

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Elizabeth Holmes and Mark Zuckerberg: The rise and fall of the black turtleneck, hoodie and jeans. Op Ed
  • Coffee drinkers stunned as new study suggests caffeine consumption worsens Alzheimer’ symptoms. Now what?
  • Healthcare stocks roar back after slump, while biotech IPOs continue stampede into pipeline.
  • Smartphones are revolutionizing medicine as new apps proliferate. Then there’s the Facebook lesson for and against trusting that your data...
  • Tiny Scottish biotech TauRx lobs bomb into Alzheimer’s fracas with Phase 3 success.
  • Novartis gets FDA nod for breakthrough leukemia treatment Kymriah; with a cost of $450,000, who’s going to get it?
  • CAR-T Therapy: Personalized medicine with the promise of a cure; payers will decide who gets it
  • Government to make August CSR payment to health insurers; meanwhile, CBO says Trump threat to Obamacare would send premiums 20%
  • Tiny Scottish biotech TauRx lobs bomb into Alzheimer’s fracas with Phase 3 success.
  • Breakthrough study linking menopause to increased risk of Alzheimer’s explains why far more women than men get the disease; what...
  • Alarming study concludes most new, pricey cancer drugs don’t work; why are we just hearing about this?
  • Rx Hall of Shame Update: Former Insys employee pleads guilty in US opioid drug probe; case against ex CEO Michael...
Copyright 2018
Ribosome by GalussoThemes.com
Powered by WordPress